Working… Menu
Trial record 3 of 6 for:    Longeveron

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02600130
Recruitment Status : Active, not recruiting
First Posted : November 9, 2015
Last Update Posted : February 18, 2021
Information provided by (Responsible Party):
Longeveron LLC

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : September 2020
Estimated Study Completion Date : March 2021